University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS

Site Details

LOCATION

1611 North West 12th Avenue

ACC East Building 1st Floor Infectious Diseases

Miami, FL. 33136-1096

Get Directions

Site Type

CRS

CRS Coordinator

Lisa Rohn

lrohn@med.miami.edu

305-243-5621

CRS Leader

Jose Castro

jcastro2@med.miami.edu

305-243-2399

Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.

COVID-19 and Mpox

Open and enrolling

A5418: A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Mpox Disease

A5418 (STOMP) is a study of tecovirimat (also known as TPOXX) for the treatment of human monkeypox virus (HMPXV) disease.